U87 and LN229 GBM cells have been utilized for blocking BiP and inducing ER stress, highlighting terminal UPR activity in response to stress, significantly enhanced upon BiP inhibition in vitro and in vivo. The gene discussed is HSPA5; the disease is glioblastoma.